Phase III data on novel, lanthanum carbonate phosphate binder presented at conference

被引：0
|
作者：
不详
机构：
来源：
DIALYSIS & TRANSPLANTATION | 2003年 / 32卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [21] Effects of lanthanum carbonate on biochemical parameters: A review of phase III trials
    Haworth, S
    Confer, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A29 - A29
  • [22] The new non-aluminum, non-calcium phosphate binder, lanthanum carbonate, is not genotoxic.
    Damment, SJP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : A20 - A20
  • [23] Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: A new phosphate binder for the treatment of hyperphosphatemia
    Joy, MS
    Finn, WF
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) : 96 - 107
  • [24] Efficacy of lanthanum carbonate monotherapy in dialysis patients previously receiving alternative phosphate-binder therapy
    Hutchison, Alastair
    Gill, Maggie
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 224 - 224
  • [25] A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
    Floege, Juergen
    Covic, Adrian C.
    Ketteler, Markus
    Rastogi, Anjay
    Chong, Edward M. F.
    Gaillard, Sylvain
    Lisk, Laura J.
    Sprague, Stuart M.
    KIDNEY INTERNATIONAL, 2014, 86 (03) : 638 - 647
  • [26] Nano-lanthanum hydroxide, a novel phosphate binder, for treating hyperphosphatemia: A preclinical study
    Ma, Zixing
    Yu, Tengfei
    Wu, Yan
    Liu, Dandan
    Zhang, Xiaofei
    Miao, Xin
    Xing, Haiyan
    Li, Gang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 909 - 916
  • [27] Overview of the pharmacokinetics of lanthanum carbonate (Fosrenol®):: A non-aluminum, non-calcium phosphate binder.
    Fiddler, G
    Stewart, AJ
    Sack, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 205A - 205A
  • [28] Efficacy of Pi-Binder Lanthanum Carbonate in Reversing Systemic Effects of a High-Phosphate Diet in Mice
    Alappan, Uma D.
    Viggeswarapu, Manjula
    Arnst, Jamie
    Beck, George R.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 624 - 624
  • [29] Lanthanum carbonate, a potent and selective phosphate binder, is transported and absorbed mainly via M cells in gastrointestinal tract
    Huang, Hui-Xia
    Liu, Hui-Xue
    Yang, Xiao-Gai
    METALLOMICS, 2023, 15 (06)
  • [30] The toxicology of lanthanum carbonate (Fosrenol®), a new non-aluminum, non-calcium phosphate binder.
    Damment, SJP
    Greaves, P
    Downes, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 204A - 204A
12345